ALK1 Protein Plays a Key Role in Binding LDL Cholesterol

The protein called ALK1 facilitated low-density lipoprotein pathway into cells. ALK1 directly bound to the lipoprotein and aided the transportation of LDL from blood into tissue.

A protein that plays an important role in the buildup of LDL (low-density lipoprotein) cholesterol in blood vessels has been identified by a team of researchers from the Yale University. The finding could lead to an additional strategy to block LDL accumulation, which could help prevent or slow the clogging of arteries that leads to heart disease, the researchers said.

Arteries become clogged with fats and cholesterol when certain proteins in the body, known as lipoproteins, combine with and transport fats in the blood to cells. Scientists have long believed that the LDL receptor molecule was responsible for the transport of LDL within cells. But given that some individuals lacking the LDL receptor still have high levels of LDL, questions remained about the mechanism.

New Vaccine More Effective To Lower Bad LDL Cholesterol Than Statins
Statins that are prescribed to lower cholesterol have some serious side effects. But the new vaccine has been found to be more powerful than statins.

‘The protein called ALK1 is an LDL-binding protein that initiates the early phases of atherosclerosis. A therapeutic approach to block ALK1 could help prevent atherosclerosis.’

To identify the mechanism, the research team screened more than 18,000 genes from the endothelium -- the inner layer of human blood vessels. They examined the transfer of LDL into endothelial cells and then focused on possible genes involved in the process.

The researchers found that a protein called ALK1 facilitated LDL's pathway into cells. "We confirmed that ALK1 directly binds to LDL," said William C. Sessa, senior author and the Alfred Gilman Professor of Pharmacology and professor of medicine (cardiology). The team also determined that the "LDL-ALK1 pathway" aided the transport of LDL from blood into tissue.

The role of ALK1 in LDL accumulation was not previously known, said Sessa.

Reimbursement Systems may Influence attainment of LDL Cholesterol Targets
There is a noticeable variation in the achievement of LDL cholesterol targets between different European countries, Dr Gitt revealed

"The discovery of ALK1 as an LDL-binding protein implies that it might initiate the early phases of atherosclerosis," he noted. "If we can find a way of blocking ALK1 using small molecules or antibodies, it might be used in combination with lipid-lowering strategies." Current lipid-lowering strategies include statins, which target LDL cholesterol levels in the blood.

A therapeutic that blocks ALK1 "would be a unique strategy for reducing the burden of atherosclerosis and be synergistic with lipid- lowering therapies," Sessa noted.

DNA is Not Destiny - Following a Healthy Lifestyle Reduces Genetic Heart Attack Risk
Even among those at high genetic risk, following a healthy lifestyle can cut in half the probability of a heart attack or similar event.

Heart disease caused by damage to blood vessels is the leading cause of death worldwide.

The study was published in Nature Communications.

60 Grams of Walnuts a Day Keep Heart Diseases At Bay!
Walnuts have a great potential to reduce LDL cholesterol, diastolic blood pressure and inflammation that are associated with cardiovascular diseases.

Source-Eurekalert